Clinical Trial Update: Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial evaluating botulinum toxin injections to prevent secondary atrial fibrillation in patients with supraventricular tachyarrh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Supraventricular Tachyarrhythmias

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Supra-ventricular Tachyarrhythmias | Phase 2 | Status: UNKNOWN